US Patent 7977342 HCV inhibiting bi-cyclic pyrimidines
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+429 characters)
Article
Patent abstract
The present invention relates to the use of bi-cyclic pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to processes for preparation of such pharmaceutical compositions. The present invention also concerns combinations of the present bi-cyclic pyrimidines with other anti-HCV agents.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Dominique Louis Nestor Ghislain Surleraux0
Kenneth Alan Simmen0
Oliver Lenz0
Pierre Jean-Marie Bernard Raboisson0
Tse-I Lin0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07977342 HCV inhibiting bi-cyclic pyrimidines US Patent 7977342 HCV inhibiting bi-cyclic pyrimidines
Infobox
Patent Number
079773420
Patent Number
79773420
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079773420
Date of Patent
July 12, 2011
0Patent Application Number
116842880
Date Filed
March 9, 2007
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07977342 HCV inhibiting bi-cyclic pyrimidines
Infobox
Is a
Patent jurisdiction
Patent number
07977342
Date of patent
July 12, 2011
Patent application number
11684288
Date Filed
March 9, 2007
Patent primary examiner
Find more entities like US Patent 7977342 HCV inhibiting bi-cyclic pyrimidines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
